Celltrion
068270.KS
#826
Rank
A$37.58 B
Marketcap
$172.63
Share price
0.00%
Change (1 day)
-14.37%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.67. In 2022 the company made an earnings per share (EPS) of $4.55 a decrease over its 2021 EPS that were of $5.41.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.50-1.2%
2022$4.55-15.84%
2021$5.4112.77%
2020$4.8070.79%
2019$2.8115.63%
2018$2.43-33.13%
2017$3.63141.17%
2016$1.518.28%
2015$1.3911.28%
2014$1.2516.37%
2013$1.07-67.42%
2012$3.3084.22%
2011$1.7962.13%
2010$1.1080.61%
2009$0.61-559.63%
2008-$0.13-123.16%
2007$0.57